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Abstract
Placental transfer of maternal calcium (Ca2 + ) is a crucial step for fetal development although the biochemical mechanisms responsible for
this process are largely unknown. This process is carried out in vivo by the placental syncytiotrophoblast layer. The aim of this study was to
define the membrane gates responsible for the syncytiotrophoblast Ca2 + entry, the first step in transplacental transfer. We have investigated
the basal Ca2 + uptake by primary culture of human term placenta syncytiotrophoblast. Kinetic studies revealed an active extracellular Ca2 +
uptake by cultured human syncytiotrophoblast. We demonstrated by Northern blot the presence of transcript for calcium transporter type 1
(CaT1) in cultured human syncytiotrophoblast and CaT1 expression was further confirmed by reverse transcription polymerase chain
reaction (RT-PCR). In addition, the expression of calcium transporter type 2 (CaT2) was revealed by RT-PCR in cultured human
syncytiotrophoblast. It has been reported that the activity of this family of Ca2 + channels is voltage-independent, and is not sensitive to L-
type Ca2 + channels agonist and antagonist. Interestingly, modulation of membrane potential by extracellular high potassium concentration
and valinomycin had no effect on the basal Ca2 + uptake of human syncytiotrophoblast. Moreover, the addition of L-type Ca2 + channel
modulators (Bay K 8644 and nitrendipine) to the incubation medium had also no effect on the basal Ca2 + uptake, suggesting that the process
is mainly voltage-independent and does not involved L-type Ca2 + channels. On the other hand, we observed that two known blockers of
CaT-mediated Ca2 + transport, namely extracellular magnesium (Mg2 + ) and ruthenium red, dose-dependently inhibited Ca2 + uptake by
cultured human syncytiotrophoblast. Therefore, our results suggest that basal Ca2 + uptake of human syncytiotrophoblast may be assured by
CaT1 and CaT2.
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1. Introduction
Mammalian fetal nutrition during gestation is dependent
on the transfer of maternal ions and nutrients by the
placenta [1–4]. Throughout gestation, the fetus acquires
all of its Ca2 + from the maternal circulation for its deve-
lopment. This ion is actively transported across the pla-
centa from the maternal to the fetal circulation, and
consequently the total Ca2 + concentration in the fetal
plasma over a wide range of species of mammals exceeds
that in the mother especially during the late part of the
gestation [5,6]. This active Ca2 + transfer is carried out in
vivo by the placental syncytiotrophoblast layer [7]. In
vitro, the cytotrophoblasts isolated from human term
placenta undergo spontaneous syncytiotrophoblastic-like
morphological and biochemical differentiation, and are
thought to reflect in vivo syncytiotrophoblast. Although
the cell isolation procedure of Kliman et al. [8] has greatly
improved the investigation of placental nutrient exchanges,
the placental Ca2 + transfer mechanisms remain to be
established. Particularly, the membrane gate for the troph-
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oblast Ca2 + entry, which constitutes the first step in
transcellular placental transfer, is not resolved. Primary
cultures of syncytiotrophoblast from human term placenta
have not been used until now to resolve this aspect and
these cells may represent numerous advantages in regard to
the in vivo situation.
A limited number of membrane channels could be
considered in the entry of Ca2 + into the cell. Ca2 + channels
with pharmacological characteristics of L-type Ca2 + chan-
nels have been functionally identified in trophoblasts in
relation to the regulation of hormonal secretions [9–12].
These characteristics include voltage dependence of activa-
tion and sensitivity to dihydropyridine and phenylalkyl-
amine organic Ca2 + channel modulators. Moreover,
capacitative Ca2 + current via store-operated channels could
also contribute to the ion entry since we have recently
reported the involvement of such conductance in cortico-
trophin-releasing factor (CRF) secretion by trophoblast cells
[13]. Other candidates for the trophoblast Ca2 + entry are
members of a subfamily related to the transient receptor
potential (TRP) family of nonselective, Ca2 + -permeable,
cation channels. This subfamily is composed of novel
highly selective Ca2 + channels that have been recently
cloned and shown to be mainly expressed in epithelium
involved in Ca 2 + transfer. Calcium transporter protein type
1 or epithelial Ca2 + channels 2 (CaT1 or ECaC2) have been
reported in intestinal epithelium [14–16] and placental
tissue (CaT-like) [17]. Calcium transporter protein type 2
or epithelial Ca2 + channels 1 (CaT2, ECaC1 or ECaC) have
been cloned from rabbit [18], rat [19] and human [20] renal
epithelium.
Expression of Ca2 + channels of the CaT/ECAC family
has been shown in human placental tissue. Barley et al. [14]
have identified transcripts from human placental tissue that
hybridize with partial cDNA of CaT1/ECaC2 and Peng
et al. [16] have reported by Northern blot the expression of
CaT1/ECaC2 in human placental tissue. Moreover, Hoen-
derop et al. [18] have demonstrated in the same tissue
transcripts that hybridize with cDNA of the rabbit ECaC
and Mu¨ller et al. [20] have reported the presence in the
human placenta of mRNA that corresponded to CaT2/
ECaC1. Accordingly, Peng et al. [21] have reported expres-
sion of both type of Ca2 + channels and reported by
quantitative real-time PCR that CaT1 is highly expressed
compared to CaT2 in placental tissue. In view of the
functional investigation of the role of CaT/ECaC family,
extracellular Mg2 + and ruthenium red have been recently
reported to be effective inhibitors of CaT-mediated Ca2 +
uptake [22].
There is no information about the expression of CaT/
ECaC and their involvement in Ca2 + uptake in cultured
human trophoblast cells isolated from human term placenta.
In the current study, we have evaluated the expression of
Ca2 + channels from the CaT/ECaC family in primary
culture of human syncytiotrophoblast and investigated its
role in basal Ca2 + uptake.
2. Materials and methods
2.1. Materials
Dulbecco’s modified Eagle medium (DMEM), newborn
calf serum and TriZolk were purchased from Life Tech-
nologies (Burlington, Ontario, Canada). Hank’s balanced
salt solution (HBSS), trypsin, DNAse, Percoll, ruthenium
red, MgCl2 and Triton X-100 were obtained from Sigma
(Oakville, Ontario, Canada). The 24-well plates were
purchased from Sarstedt (Montreal, Quebec, Canada).
Fetal bovine serum (FBS) and enzyme-linked immuno-
sorbent assay (ELISA) for human chorionic gonadotropin
(hCG) were obtained from Medicorp (Montreal, Quebec,
Canada). The fluorescein isothiocyanate (FITC)-conju-
gated monoclonal antibody against cytokeratin 7 was
purchased from Accurate Chemical and Scientific (West-
bury, NY, USA). Bovine serum albumin (BSA), [ethyl-
enebis(oxyethylenenitrilo)]-tetraacetic acid (EGTA), 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
the random hexamer primers were obtained from Roche
Molecular Biochemicals (Laval, Quebec, Canada). Radio-
labeled Ca2 + (45CaCl2) was purchased from ICN Bio-
medicals (Irvine, CA, USA). The bicinchoninic acid
(BCA) reagent was obtained from Pierce (Brockville,
Ontario, Canada). Omniscriptk RT and Taq PCR core
kits were purchased from Qiagen (Mississauga, Ontario,
Canada). The restriction enzymes (XhoI and SacI) were
purchased from Amersham Pharmacia Biotech (Baie
d’Urfe´, Que´bec, Canada). The RNA millenniumk size
markers for Northern blot were purchased from Ambion
(Austin, TX, USA). The thermal cycler GeneAmp PCR
system 2400 was obtained from Perkin Elmer (Markham,
Ontario, Canada).
2.2. Human placental trophoblast isolation and purity
evaluation
Cytotrophoblasts were isolated from human term placen-
tas according to the procedure of Kliman et al. [8]. The
placentas were obtained from normal deliveries at the
Pavilion St-Luc of the Centre Hospitalier Universitaire de
Montre´al (Quebec, Canada) and were immerged in DMEM
for no more than 1 h after delivery. Briefly, fetal membranes
and maternal decidua were removed and villous tissue was
cut into approximately 1-in. cubes and washed extensively
with saline in order to remove blood. The tissue was then
incubated three times in HBSS containing 1.5–1.6 mg/ml
trypsin and 0.2 mg/ml DNAse at 37 jC for 30 min. After
each incubation, the supernatant was removed and replaced
by fresh digestion media. The supernatant was layered on to
newborn calf serum and centrifuged at 1215 g for 15 min.
Pellets were resuspended in DMEM, deposited on top of a
discontinuous 5% to 40% Percoll gradient, and centrifuged
at 507 g for 20 min. Cytotrophoblast layers were removed
and washed in DMEM. Cells were seeded at approximately
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1.7 106 cells/well in 24-well plates. The medium was
refreshed daily with DMEM containing 10% FBS.
The purity of the cytotrophoblast preparations was eval-
uated by flow cytometry using FITC-conjugated monoclo-
nal antibody against cytokeratin 7 following the procedure
described by Campbell et al. [23]. It has been reported that
anti-cytokeratin 7 antibody was specific for trophoblast cells
[24,25]. Approximately 500000 cells from the preparations
were fixed in methanol at  20 jC for 20 min, washed in
phosphate-buffered saline (PBS) and then incubated in PBS
containing FBS (dilution 1:50) for 30 min to eliminate
nonspecific binding. Thereafter, cells were washed with
PBS and incubated with mouse monoclonal anti-human
cytokeratin 7 in PBS containing 0.2% BSA for 45 min at
room temperature in the dark. Controls were performed by
omitting the antibody. Cells were then washed in PBS and
analysed by flow cytometry using FACScan system (Becton
Dickinson, San Jose, CA, USA) with WinMDI software.
2.3. hCG secretion of trophoblast
Secretion of hCG by primary culture of trophoblast was
evaluated by ELISA as described previously [12]. For the
everyday follow-up of hormone release or secretion under
treatments, the incubation media were retrieved, centrifuged
and supernatants were frozen at  20 jC until measure-
ments.
2.4. Ca2+ uptake studies
Ca2 + uptake studies were performed on cells from 4-day
trophoblast cultures. Briefly, cells were washed twice with
the Ca2 + uptake buffer (HBSS containing 1.26 mM CaCl2,
10 mM HEPES and 0.1% BSA) and allowed to equilibrate
in the same buffer (250 Al) for 10 min. Thereafter, cells were
incubated at 37 jC for different intervals of time following
the addition of 250 Al of uptake buffer containing 45CaCl2
(2–4 ACi/well). The incubation was stopped by aspiration
of the uptake buffer. The cells were washed three times with
500 Al of ice cold PBS containing 4 mM EGTA (to
eliminate the nonspecific component of the uptake [26]),
and then solubilized in PBS containing 1% Triton X-100.
The cell-associated radioactivity was measured by a h-
scintillation 1400TM Wallac counter. The cellular protein
content of each well was evaluated by spectrophotometric
quantification using the BCA reagent with BSA as standard.
The Ca2 + uptake is expressed as nanomoles of Ca2 + (from
specific activity) per milligram of cellular proteins.
2.5. Cell expression of Ca2+channels from the CaT/ECaC
family
Northern blotting was performed with total RNA isolated
from 4-day cultured cells using TriZolk according to the
manufacturer instructions. RNA was separated by electro-
phoresis on 1% agarose gel and thereafter transferred to
Hybond N nylon membrane. Membrane was hybridized in
the presence of 50% formamide at 42 jC overnight. A
cDNA (785 bp) amplified using specific primers for CaT1
exon 15 (accession numbers AF304463; sense primer, 5V-
GCTCTGAGGATTTGGACAAAGACTC-3V; antisense pri-
mer, 5V-TCAGGGATCCGAAAACGACTT-3V) was 32P-
labeled and used as probe. The presence of transcripts for
CaT1 and CaT2 (accession number AF304464) in 4-day
trophoblast cultures was investigated by PCR using specific
primers for CaT1 (sense primer in exon 1, 5V-CTCTGCCT-
ATGGAGCAAGTTCTGC-3V; antisense primer in exon 7,
5V-GAGAGTCGAGGTCAGTGGTCC-3V), and for CaT2
(sense primer in exon 9, 5V-GGCCTATGAGACACGT-
GAAGATATC-3V; antisense primer in exon 13, 5V-ATA-
GAATTGCCCCAGACTGGT-3V). Isolated RNA was
reversed transcribed using random hexamer primers and
Omniscriptk RT kit. PCRs were performed using Taq PCR
core kit in a thermal cycler GeneAmp PCR system 2400.
The specificity of the amplicon was evaluated with restric-
tion enzymes.
2.6. Statistical analysis
Statistical analyses were performed using unpaired Stu-
dent’s t-test. Differences were considered significant when P
values were < 0.05. Data were expressed as the meanF S.E.
3. Results and discussion
3.1. Purity of the cytotrophoblast preparations
Following the isolation of cytotrophoblast cells from
human term placenta, the purity of the cell preparations
were ascertained by flow cytometry using mouse mono-
clonal antibody against human cytokeratin 7 (trophoblast
specific). Fig. 1 shows representative data where more than
96% of the cells were positive for cytokeratin 7. This
percentage of purity was considered acceptable by other
investigators [8,23,25]. Subsequent investigations of Ca2 +
uptake and channel expression would be representative of
the trophoblast characteristics.
3.2. Hormonal status of the primary cultures of human
trophoblasts
In order to verify the differentiation of isolated cytotro-
phoblast cells into functional syncytiotrophoblast, we meas-
ured over a period of 7 days the secretion of hCG, a well
known marker of this process [8]. Fig. 2 shows a profile of
the relative secretion of hCG by freshly isolated cytotro-
phoblasts from term placentas (37–40 weeks of pregnancy).
The hCG secretion was very modest over the first 24 h of
culture. The secretion then increased reaching a peak at 4
days of culture (typical value of 1456 mU/well/24 h for a
38-week placenta), and declined thereafter. These results
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suggest that our cytotrophoblast preparations were highly
purified, without syncytial fragments, since hCG secretion
over the first 24 h was barely detectable. These cells
differentiated into syncytiotrophoblast during 4 days of
culture as indicated by the increase of hCG secretion,
confirming what was previously described [8]. The follow-
ing decrease of hCG secretion has been observed previously
[24,27] but explanation remains obscure although apoptosis
could explained such decrease in hCG secretion [28].
Therefore, we performed subsequent experiments with 4-
day cultured trophoblasts.
3.3. Ca2+ uptake by primary culture of human trophoblasts
The cells exhibited an active extracellular Ca2 + uptake
(Fig. 3) with a rapid uptake during the first 2 min with an
initial velocity (Vi) of 6.02F 0.29 nmol/mg/min, which
gradually reached a plateau (14.55F 1.82 nmol/mg protein
at 30 min of incubation). This uptake was proportional to
the concentration of Ca2 + in the incubation medium (Fig.
4). The kinetic of Ca2 + uptake by syncytiotrophoblast has
similar shape compared to basal Ca2 + uptake by undiffer-
entiated cytotrophoblast cell line BeWo [26] with, however,
a higher Vi (compared to 4.17F 0.25, P < 0.005) and a
higher level of cell-associated 45Ca2 + at the plateau (com-
pared to 8.65F 0.84 nmol/mg protein, P < 0.025). The
Ca2 + uptake studies using whole cell are a reflection of
the dynamic homeostasis of cellular Ca2 + where mecha-
nisms of Ca2 + entry and exit coexist, resulting in the
Fig. 1. Flow cytometry data of a representative preparation of cytotropho-
blast cells from human term placenta incubated with PBS alone (A) or with
monoclonal antibody against cytokeratin 7 (B). FL1-height corresponds to
arbitrary intensity of FITC staining and SSC-height corresponds to side
scatter an arbitrary evaluation of cell size.
Fig. 2. hCG secretion of trophoblast primary culture from human term
placenta in function of culture time. The data are expressed as relative
secretion of hCGF S.E. of four cell preparations from placentas of 37–40
weeks of pregnancy. *P< 0.025, **P < 0.001.
Fig. 3. Time-course of Ca2 + uptake by 4-day trophoblast culture cells. The
results represent the meanF S.D. of experiments performed in duplicates
with cell preparations from three to five placentas.
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maintenance of an adequate intracellular Ca2 + level. The
first portion of the kinetic curve (first 5 min) more likely
represents Ca2 + uptake mechanisms and our results indi-
cated higher Ca2 + uptake capacity of syncytiotrophoblast
compared to BeWo cells (according to respective Vi). The
establishment of a gradual plateau around 5 min of incuba-
tion has been generally viewed as an equilibrium of the
radiolabel between the medium and the intracellular space.
The level of cell-associated 45Ca2 + observed at the plateau
also showed the extend of intracellular Ca2 + retention that
depends on factors such as the interaction of Ca2 + with
intracellular proteins or its sequestration in intracellular
membrane compartments. The intracellular Ca2 + retention
capacity seems higher in the trophoblast cells compared to
BeWo cells (according to the difference in the level of cell
associated 45Ca2 + at the plateau). In renal and intestinal
epithelium, the Ca2 + transfer is modulated by the expres-
sion of specific Ca2 + binding proteins (calbindins). The
expression of such calbindins in primary culture of troph-
oblasts of human term placenta has not been investigated
until now although calbindin expression has been reported
in placental tissue [20].
3.4. Expression of Ca2+ channels of the CaT/ECAC family
in human trophoblast cells
The expression of CaT1 and CaT2 was evaluated by
reverse transcription polymerase chain reaction (RT-PCR) in
4-day trophoblast cultures using specific primers. Fig. 5A
shows that an amplicon of 795 bp corresponding to the
expected size was intensely amplified with total RNA from
trophoblasts cultured for 4 days using another set of primers
for CaT1. Specificity of the amplicon was demonstrated
following digestion with SacI (fragments of 490 and 305 bp,
lane 3). Fig. 5B shows that an amplicon of 448 bp
corresponding to the expected size was intensely amplified
with total RNA from 4-day cultured trophoblast using
specific primers for CaT2. Specificity of the amplicon was
demonstrated following digestion with XhoI (fragments of
282 and 166 bp, lane 3). Expression of CaT1 was also
investigated in cultured human syncytiotrophoblast by
Northern blotting. A cDNA probe (785 bp) was generated
by PCR with primers specific to CaT1 (Fig. 6A). The
expression of CaT1 as transcript of approximately 3 kilo-
base (kb), of size expected according to the sequence of
GenBank, was revealed by Northern blot in cultured syn-
cytiotrophoblast (Fig. 6B). However, expression of CaT2
could not be revealed by Northern blot with PCR-generated
CaT2 specific cDNA probe and may be due to low sensi-
Fig. 4. Ca2 + uptake in function of different Ca2 + concentrations. Cells
were incubated for 1 min at 37 jC in modified HBSS (without calcium)
containing increasing amount of Ca2 + (0.0325–3 mM) with 45CaCl2. The
results represent the meanF S.E. of experiments performed in duplicates
with cell preparations from three placentas.
Fig. 5. Evaluation of the expression of Ca2 + channels of the CaT/ECaC
family in primary culture of trophoblast from human term placenta. (A)
PCRs were performed with specific primers for CaT1 (lane 2) and the
amplicon was digested with SacI (lane 3). Lane 1: 100-bp ladder. (B) PCRs
were performed with primers for CaT2 (lane 2) and the amplicon was
digested with XhoI (lane 3). Lane 1: 50-bp ladder.
Fig. 6. Representative Northern blot of cultured human syncytiotrophoblast
RNA with CaT1 probe. (A) cDNA amplified from total RNA and used as
CaT1 probe. Lane 1: 100-bp ladder. (B) Total RNA (10 Ag) was hybridized
with cDNA CaT1 probe. Size markers are indicated (kb).
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tivity of the technique for low level of expression of CaT2
as reported by Peng et al. [21].
3.5. Effect of cell membrane potential and L-type Ca2+
channel modulators on the Ca2+ uptake
Basal Ca2 + uptake of trophoblast cultures was not
modulated by cell depolarisation with high potassium (40
mM) in the incubation medium or by hyperpolarisation with
valinomycin (Fig. 7A). Furthermore, modulators of the
activity of L-type Ca2 + channels (namely Bay K 8644 as
an agonist and nitrendipine as an antagonist) had no effect
on the basal Ca2 + uptake of trophoblast cultures (Fig. 7B).
Cell treatments with KCl and Bay K 8644 were, however,
effective to stimulate hCG secretion (57.8F 12.3 and
62.2F 13.8 mU/well/12 h for KCl and Bay K 8644,
respectively compared to 34.2F 8.7 mU/well/12 h for a
40-week placenta) as previously reported [10]. Neverthe-
less, such Ca2 + uptake that trigger hCG secretion may be
minimal and localized, and would not be of major impact on
global cell Ca2 + uptake. Recently, we have reported similar
insensitivity of basal Ca2 + uptake by BeWo cells [26],
indicating that voltage-sensitive Ca2 + channels are minor
contributor in the basal Ca2 + uptake. For short incubation
period (1 and 5 min) where Ca2 + uptake is likely to depend
principally on membrane transfer, the various treatments
(KCl, valinomycin, Bay K 8644 and nitrendipine) had not
effect on this initial uptake. This insensitivity of Ca2 +
uptake under these conditions argues well with the minor
contribution of L-type Ca2 + channels in basal Ca2 + uptake
by cultured trophoblast cells. For longer incubation period of
30 min, KCl (13.45F 1.39 nmol/mg protein), valinomycin
(14.86F 0.90 nmol/mg protein), Bay K 8644 (12.01F 0.98
nmol/mg protein) and nitrendipine (14.97F 1.00 nmol/mg
Fig. 7. Effect of cell membrane potential and L-type Ca2 + channel
modulators on the Ca2 + uptake of trophoblast cells. The cells were
incubated in the presence of (A) 40 mM KCl, 10 AM valinomycin or in
control medium (Basal), and in the presence of (B) 2 AM nitrendipine, 10
AM Bay K 8644 or in control medium (Basal). The results are expressed as
the ratio of the Ca2 + uptake of treated cells compared with cells incubated
in control conditions (vehicle or isoosmotic medium). Data represent the
meanF S.E. of experiments performed in duplicates with cell preparations
from three placentas.
Fig. 8. Dose– response analysis for extracellular Mg2 + or ruthenium red
inhibition of Ca2 + uptake by 4-day cultured trophoblasts. (A) Cells were
incubated for 1 min (.), 5 min (o) and 15 min (5) at 37 jC in modified
HBSS (with 100 AM Ca2 + and without Mg2 + ) containing increasing
amount of Mg2 + (0.001, 0.5, 1, 10 and 50 mM) and 2–4 ACi of 45CaCl2.
(B) Cells were preincubated with increasing concentrations of ruthenium
red (0.05, 5, 10, 100 and 1000 AM) for 10 min and uptakes were performed
in HBSS for 1 min (.), 5 min (o) and 15 min (5). Ca2 + uptake data were
normalised to the corresponding uptake in the absence of Mg2 + or
ruthenium red. The results represent the meanF S.E. of experiments
performed in duplicates with cell preparations from three to four placentas.
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protein) did not induced significant effect compared to basal
condition (14.23F 0.94 nmol/mg protein). Insensitivity of
the basal placental Ca2 + uptake or transfer toward voltage-
sensitive Ca2 + channel blockers was also observed by Stulc
et al. [29] with perfused human placental cotyledon, by
Brunette and Leclerc [30] and Kamath et al. [31] with brush
border membrane vesicles. Therefore, our current results are
in agreement with the insensitivity of basal placental Ca2 +
uptake toward voltage-sensitive Ca2 + channel blockers. It
also appears that the activity of L-type Ca2 + channels in
trophoblast cells is of minor contribution in the Ca2 + uptake
under basal conditions. The role of such L-type Ca2 + chan-
nels in trophoblast cells may reside more likely in the
regulation of protein secretion (especially for hCG, placental
lactogen and CRF) as previously reported [9–13].
3.6. Effect of extracellular Mg2+ and ruthenium red on the
Ca2+ uptake
We performed dose-response inhibition of human syn-
cytiotrophoblast Ca2 + uptake by extracellular Mg2 + and
ruthenium red. Fig. 8A shows that increasing extracellular
concentrations of Mg2 + dose-dependently inhibited cul-
tured syncytiotrophoblast Ca2 + uptake evaluated at 1, 5
and 15 min with IC50 of 0.96F 0.09 mM. Hoenderop
et al. [22] have reported IC50 of 1.4 mM for CaT1/
ECaC2 and of 0.33 mM for CaT2/ECaC1 [32] by patch-
clamp studies. Our current results are in agreement with
these effective concentrations. Fig. 8B shows that ruthe-
nium red led to a dose-dependent inhibition of cultured
syncytiotrophoblast Ca2 + uptake evaluated at 1, 5 and 15
min with IC50 of 9.02F 1.75 AM. Similar IC50 of 9 AM
for CaT1/ECaC2 and of 121 AM for CaT2/ECaC1 have
been obtained by patch-clamp analysis [22]. Our results
for ruthenium red inhibition were also in agreement with
effective concentrations for CaT/ECaC-mediated Ca2 +
uptake inhibition. Longer incubation period led to similar
effect for extracellular Mg2 + (3.58F 0.39 vs. 1.22F 0.21
nmol/mg protein/15 min for basal compared to 50 mM
Mg2 + , P < 0.005) and for ruthenium red (10.58F 1.52
vs. 6.85F 1.12 nmol/mg protein/15 min for basal com-
pared to 1000 AM ruthenium red, P < 0.005).
Our results indicate for the first time the expression of
CaT (namely CaT1 and CaT2) in primary culture of
trophoblasts from human term placenta. Members of this
family of Ca2 + channels are voltage-insensitive and are not
modulated by L-type Ca2 + channels modulators, two char-
acteristics of the basal Ca2 + uptake observed with tropho-
blast cells in the current study. Moreover, two potent
blockers of CaT/ECaC-mediated Ca2 + uptake dose-depend-
ently inhibited Ca2 + uptake of cultured human syncytio-
trophoblast with IC50 similar to concentrations previously
reported [22,32]. Our results suggest that Ca2 + channels of
CaT/ECaC family are major contributors for the basal Ca2 +
uptake of cultured human syncytiotrophoblast. Interestingly,
we have previously reported the involvement of capacitative
Ca2 + current in CRF secretion by trophoblast cells [13]. In
recent studies, it was shown that the CaT1 displays the
properties of the Ca2 + -release-activated Ca2 + channel [33],
suggesting that CaT1 is functionally coupled to the IP3
receptor and can be activated by depletion of the intra-
cellular Ca2 + stores. Further investigations are warranted in
order to ascertain the functional role of CaT1 and CaT2 in
the placental physiology.
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